152 related articles for article (PubMed ID: 29999584)
1. Heterogeneity of lipidomic profiles among lung cancer subtypes of patients.
Lv J; Gao D; Zhang Y; Wu D; Shen L; Wang X
J Cell Mol Med; 2018 Oct; 22(10):5155-5159. PubMed ID: 29999584
[TBL] [Abstract][Full Text] [Related]
2. Clinical lipidomics in understanding of lung cancer: Opportunity and challenge.
Zhang L; Zhu B; Zeng Y; Shen H; Zhang J; Wang X
Cancer Lett; 2020 Feb; 470():75-83. PubMed ID: 31655086
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.
Sánchez-Rodríguez P; Rodríguez MC; Sánchez-Yagüe J
Tumour Biol; 2015 Jul; 36(7):5687-98. PubMed ID: 25702090
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
5. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
6. Trans-omic profiling between clinical phenoms and lipidomes among patients with different subtypes of lung cancer.
Zhu Z; Zhang L; Lv J; Liu X; Wang X
Clin Transl Med; 2020 Aug; 10(4):e151. PubMed ID: 32898330
[TBL] [Abstract][Full Text] [Related]
7. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients.
Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V
J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259
[TBL] [Abstract][Full Text] [Related]
8. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of UNC-112 protein in lung cancer].
Qiang GL; Yu QD; Xiao F; Guo YQ
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(47):3776-8. PubMed ID: 24548397
[TBL] [Abstract][Full Text] [Related]
10. The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer.
Jin Y; Liu Y; Zhang J; Huang W; Jiang H; Hou Y; Xu C; Zhai C; Gao X; Wang S; Wu Y; Zhu H; Lu S
PLoS One; 2015; 10(12):e0144187. PubMed ID: 26642205
[TBL] [Abstract][Full Text] [Related]
11. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK
Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856
[TBL] [Abstract][Full Text] [Related]
12. Multiplex genomic test of mutation and fusion genes in small biopsy specimen of lung cancer.
Oshita F; Kasajima R; Miyagi Y
J Exp Ther Oncol; 2016 Jul; 11(3):189-194. PubMed ID: 28471124
[TBL] [Abstract][Full Text] [Related]
13. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.
Wu C; Hao H; Li L; Zhou X; Guo Z; Zhang L; Zhang X; Zhong W; Guo H; Bremner RM; Lin P
J Thorac Oncol; 2009 Jan; 4(1):30-6. PubMed ID: 19096303
[TBL] [Abstract][Full Text] [Related]
14. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Oser MG; Niederst MJ; Sequist LV; Engelman JA
Lancet Oncol; 2015 Apr; 16(4):e165-72. PubMed ID: 25846096
[TBL] [Abstract][Full Text] [Related]
15. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
16. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs associated with increased AKT gene number in human lung carcinoma.
Goto A; Dobashi Y; Tsubochi H; Maeda D; Ooi A
Hum Pathol; 2016 Oct; 56():1-10. PubMed ID: 27189341
[TBL] [Abstract][Full Text] [Related]
18. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
19. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
Volm M; Koomägi R; Efferth T; Mattern J
Anticancer Res; 2002; 22(4):2321-4. PubMed ID: 12174921
[TBL] [Abstract][Full Text] [Related]
20. A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer.
Liu L; Song X; Li X; Xue L; Ding S; Niu L; Xie L; Song X
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2713-2723. PubMed ID: 31552488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
